Is Trump’s most-favoured-nation drug policy keeping medicine from Canada? Evidence is mixed
MFN deals force drug companies to lower prices in the U.S. by raising them in other countries
How the newspaper covers this story
- The Globe and MailCanada
Is Trump’s most-favoured-nation drug policy keeping medicine from Canada? Evidence is mixed
MFN deals force drug companies to lower prices in the U.S. by raising them in other countries



